内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Jones Jeffrey Alan. Director active across 2 companies, notably Cullinan Oncology, Inc.. In total, 14 filings have been logged. Breakdown: 0 buy · 11 sells. Total volume traded: €275k. Activity tracked since 17 February 2023. The latest transaction was filed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Jones Jeffrey Alan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
4,582 股@ US$14.4723.2% 占其流量Common StockSEC:0001193125-26-072000:0
4,982 股@ US$13.6223.8% 占其流量Common StockSEC:0001193125-26-064257:0
4,632 股@ US$9.6729.7% 占其流量Common StockSEC:0001193125-25-327030:0
4,895 股@ US$8.5344.2% 占其流量Common StockSEC:0000950170-25-029201:0
65,000 股0Common StockSEC:0000950170-25-025028:0
4,632 股@ US$11.4155.8% 占其流量Common StockSEC:0000950170-24-139124:0
62,500 股0Common StockSEC:0000950170-24-019455:0
1,860 股@ US$8.5043.6% 占其流量Common StockSEC:0000950170-23-072756:0
386 股@ US$8.228.8% 占其流量Common StockSEC:0000950170-23-071987:0
387 股@ US$12.9413.9% 占其流量Common StockSEC:0000950170-23-029161:0
394 股@ US$8.769.7% 占其流量Common StockSEC:0000899243-23-013361:0
392 股@ US$10.7111.6% 占其流量Common StockSEC:0000950170-23-013705:0
390 股@ US$11.3212.5% 占其流量Common StockSEC:0000899243-23-009717:0
60,000 股0Common StockSEC:0000899243-23-005728:0
About Jones Jeffrey Alan
Jeffrey Alan Jones is Chief Medical Officer at Cullinan Oncology, Inc. and Cullinan Therapeutics, Inc. He has filed 14 filings in total, and across the 14 sampled filings between 2023-02-21 and 2026-02-25, the recorded transactions are all sales, for a total of EUR 275393.